141 related articles for article (PubMed ID: 21106456)
21. Blocking sodium channels to treat neuropathic pain.
Priest BT; Kaczorowski GJ
Expert Opin Ther Targets; 2007 Mar; 11(3):291-306. PubMed ID: 17298289
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML
Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
Ma X; Poon TY; Wong PT; Chui WK
Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
[TBL] [Abstract][Full Text] [Related]
24. Sodium channel blockers for the treatment of neuropathic pain.
Bhattacharya A; Wickenden AD; Chaplan SR
Neurotherapeutics; 2009 Oct; 6(4):663-78. PubMed ID: 19789071
[TBL] [Abstract][Full Text] [Related]
25. Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain.
Shao PP; Ok D; Fisher MH; Garcia ML; Kaczorowski GJ; Li C; Lyons KA; Martin WJ; Meinke PT; Priest BT; Smith MM; Wyvratt MJ; Ye F; Parsons WH
Bioorg Med Chem Lett; 2005 Apr; 15(7):1901-7. PubMed ID: 15780630
[TBL] [Abstract][Full Text] [Related]
26. Novel sodium channel antagonists in the treatment of neuropathic pain.
Rivara M; Zuliani V
Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
[TBL] [Abstract][Full Text] [Related]
27. Design and assessment of a potent sodium channel blocking derivative of mexiletine for minimizing experimental neuropathic pain in several rat models.
Weston RM; Subasinghe KR; Staikopoulos V; Jarrott B
Neurochem Res; 2009 Oct; 34(10):1816-23. PubMed ID: 19504185
[TBL] [Abstract][Full Text] [Related]
28. Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain.
Liang J; Brochu RM; Cohen CJ; Dick IE; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Meinke PT; Priest BT; Schmalhofer WA; Smith MM; Tarpley JW; Williams BS; Martin WJ; Parsons WH
Bioorg Med Chem Lett; 2005 Jun; 15(11):2943-7. PubMed ID: 15878274
[TBL] [Abstract][Full Text] [Related]
29. 2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2.
Rivara M; Baheti AR; Fantini M; Cocconcelli G; Ghiron C; Kalmar CL; Singh N; Merrick EC; Patel MK; Zuliani V
Bioorg Med Chem Lett; 2008 Oct; 18(20):5460-2. PubMed ID: 18818069
[TBL] [Abstract][Full Text] [Related]
30. Are sodium channel blockers useless in peripheral neuropathic pain?
Sindrup SH; Jensen TS
Pain; 2007 Mar; 128(1-2):6-7. PubMed ID: 17055164
[No Abstract] [Full Text] [Related]
31. A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain.
Hoyt SB; London C; Abbadie C; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Priest BT; Smith MM; Warren VA; Thomas-Fowlkes BS; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2013 Jun; 23(12):3640-5. PubMed ID: 23652221
[TBL] [Abstract][Full Text] [Related]
32. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
Matthews EA; Bee LA; Stephens GJ; Dickenson AH
Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
[TBL] [Abstract][Full Text] [Related]
33. Bioavailable pyrrolo-benzo-1,4-diazines as Na(v)1.7 sodium channel blockers for the treatment of pain.
Yang SW; Ho GD; Tulshian D; Bercovici A; Tan Z; Hanisak J; Brumfield S; Matasi J; Sun X; Sakwa SA; Herr RJ; Zhou X; Bridal T; Urban M; Vivian J; Rindgen D; Sorota S
Bioorg Med Chem Lett; 2014 Nov; 24(21):4958-62. PubMed ID: 25288187
[TBL] [Abstract][Full Text] [Related]
34. Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.
Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
Bioorg Med Chem Lett; 2014 May; 24(9):2057-61. PubMed ID: 24726803
[TBL] [Abstract][Full Text] [Related]
35. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain.
Yogeeswari P; Ragavendran JV; Sriram D; Kavya R; Vanitha K; Neelakantan H
Pharmacology; 2008; 81(1):21-31. PubMed ID: 17785996
[TBL] [Abstract][Full Text] [Related]
36. A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats.
McGaraughty S; Chu KL; Scanio MJ; Kort ME; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2008 Mar; 324(3):1204-11. PubMed ID: 18089840
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a novel class of isoxazoline voltage gated sodium channel blockers.
Shao PP; Ye F; Weber AE; Li X; Lyons KA; Parsons WH; Garcia ML; Priest BT; Smith MM; Felix JP; Williams BS; Kaczorowski GJ; McGowan E; Abbadie C; Martin WJ; McMasters DR; Gao YD
Bioorg Med Chem Lett; 2009 Sep; 19(18):5329-33. PubMed ID: 19674896
[TBL] [Abstract][Full Text] [Related]
38. [The role of voltage-gated sodium channels in neuropathic pain].
Dong H; Hu SJ
Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):61-3. PubMed ID: 15881349
[No Abstract] [Full Text] [Related]
39. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.
Joshi SK; Mikusa JP; Hernandez G; Baker S; Shieh CC; Neelands T; Zhang XF; Niforatos W; Kage K; Han P; Krafte D; Faltynek C; Sullivan JP; Jarvis MF; Honore P
Pain; 2006 Jul; 123(1-2):75-82. PubMed ID: 16545521
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
